The proliferation of the A549 lung cancer cell line in response to CXCL12 was found to be reduced by the downregulation of CXCR4 expression by the pBSilence1.1-siRNA-CXCR4 vector, as determined by MTT assay. The gene discussed is CXCR4; the disease is lung cancer.